Sample records for MYOSINE (myosin)
from WorldWideScience.org

Sample records 1 - 6 shown.



1

tests-genetiques_expertauteur.p.PDF


Tests génétiques Questions scientifiques, médicales et sociétales Expertise collective Ce rapport présente les travaux du groupe d'experts réunis par l'Inserm dans le cadre de la procédure d'expertise collective (annexe 1), pour répondre à la demande de la Caisse nationale d'assurance maladie des travailleurs ...

Institut National de la Sante et de la Recherche Medicale (French)

2

The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.

Gilligan, D M; Kusnierczyk, B; Michalak, E; al-Mahdawi, S; Cleland, J; Chojnowska, L; Chamberlain, S; Nihoyannopoulos, P

BACKGROUND--Mutations in the cardiac beta myosin heavy chain gene causing hypertrophic cardiomyopathy have been identified, and to assist both diagnosis and prediction of outcome attempts have been made to correlate phenotype and genotype. Two new mutations in codon 403 of the gene in three unrelate...

DRIVER (French)

3

Physical activity, Contexts and effects on health, Synthesis and recommendations


Physical activity Contexts and effects on health Synthesis and recommendations This document summarises the work of the group of experts assembled by Inserm as part of the collective expert report procedure (appendix) carried out at the request of the French Ministry of Youth, Sports and Community Development ...

Institut National de la Sante et de la Recherche Medicale (French)

4

Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy.

Oakley, C; Nihoyannopoulos, P; al-Mahdawi, S; Cleland, J; Chamberlain, S; Gilligan, D; Williamson, R; French, J; Choudhury, L

OBJECTIVE--To investigate the molecular genetic basis of the cause of disease in a family with hypertrophic cardiomyopathy. BACKGROUND--Mutation within the beta cardiac myosin heavy chain gene has been shown to be the pathogenetic mechanism underlying the disease in several families, though clear ev...

DRIVER (French)

5

But : stratifier le risque cardiaque via lutilisatio de biomarqueurs sériques


Intérêt du dosage des peptides natriurétiques dans la prise en charge d'une défaillance cardiaque Alexandre Mebazaa, MD, PhD Hôpital Lariboisière, University Paris 7, U942 Inserm Paris, France Diagnostic Accuracy of BNP Optimal cut-off point determined @ 100 pg/ml 1.0 BNP=50 pg/ml BNP=80 pg/ml BNP=100 ...

Institut National de la Sante et de la Recherche Medicale (French)

6

Myosin cross-bridge orientation in rigor and in the presence of nucleotide studied by electron spin resonance.

Ajtai, K; Burghardt, T P; French, A R

The tilt series electron spin resonance (ESR) spectrum from muscle fibers decorated with spin labeled myosin subfragment 1 (S1) was measured from fibers in rigor and in the presence of MgADP. ESR spectra were measured at low amplitude modulation of the static magnetic field to insure that a minimum ...

DRIVER (French)